Full Text Available
Note: Clicking the button above will open the full text document at the original institutional repository in a new window.
Efficacy of CDK4/6 Inhibitor Plus Aromatase Inhibitor versus Fulvestrant in Chinese Patients with Hormone Receptor-Positive and Human Epidermal Growth Factor Receptor 2-Negative (HR+/HER2-) Advanced Breast Cancer
Saved in:
| Published in: | Breast Cancer : Targets and Therapy |
|---|---|
| Format: | Online Article RSS Article |
| Published: |
2026
|
| Subjects: | |
| Tags: |
No Tags, Be the first to tag this record!
|
| _version_ | 1868847763342491648 |
|---|---|
| collection | WordPress RSS FRELIP Feed Integration |
| container_title | Breast Cancer : Targets and Therapy |
| description | |
| discipline_display | Oncology |
| discipline_facet | Oncology |
| format | Online Article RSS Article |
| genre | Journal Article |
| id | rss_article:94979 |
| institution | FRELIP |
| journal_source_facet | Breast Cancer : Targets and Therapy |
| last_indexed | 2026-06-24T03:35:13.062Z |
| publishDate | 2026 |
| publishDateSort | 2026 |
| record_format | rss_article |
| spellingShingle | Efficacy of CDK4/6 Inhibitor Plus Aromatase Inhibitor versus Fulvestrant in Chinese Patients with Hormone Receptor-Positive and Human Epidermal Growth Factor Receptor 2-Negative (HR+/HER2-) Advanced Breast Cancer Oncology General Oncology |
| sub_discipline_display | General |
| sub_discipline_facet | General |
| subject_display | Oncology General Oncology |
| subject_facet | Oncology General Oncology |
| title | Efficacy of CDK4/6 Inhibitor Plus Aromatase Inhibitor versus Fulvestrant in Chinese Patients with Hormone Receptor-Positive and Human Epidermal Growth Factor Receptor 2-Negative (HR+/HER2-) Advanced Breast Cancer |
| title_alt | Eficacia del inhibidor de CDK4/6 más inhibidor de aromatasa versus fulvestrant en pacientes chinas con cáncer de mama avanzado con receptor hormonal positivo y receptor del factor de crecimiento epidérmico humano 2 negativo (RH+/HER2-) Efficacité de l'inhibiteur de CDK4/6 plus inhibiteur de l'aromatase versus fulvestrant chez les patientes chinoises atteintes d'un cancer du sein avancé à récepteurs hormonaux positifs et HER2 négatif (RH+/HER2-) Eficácia do Inibidor de CDK4/6 mais Inibidor de Aromatase versus Fulvestranto em Pacientes Chinesas com Câncer de Mama Avançado Receptor Hormonal-Positivo e Receptor do Fator de Crescimento Epidérmico Humano 2-Negativo (RH+/HER2-) |
| title_auth | Efficacy of CDK4/6 Inhibitor Plus Aromatase Inhibitor versus Fulvestrant in Chinese Patients with Hormone Receptor-Positive and Human Epidermal Growth Factor Receptor 2-Negative (HR+/HER2-) Advanced Breast Cancer |
| title_es_txt | Eficacia del inhibidor de CDK4/6 más inhibidor de aromatasa versus fulvestrant en pacientes chinas con cáncer de mama avanzado con receptor hormonal positivo y receptor del factor de crecimiento epidérmico humano 2 negativo (RH+/HER2-) |
| title_fr_txt | Efficacité de l'inhibiteur de CDK4/6 plus inhibiteur de l'aromatase versus fulvestrant chez les patientes chinoises atteintes d'un cancer du sein avancé à récepteurs hormonaux positifs et HER2 négatif (RH+/HER2-) |
| title_full | Efficacy of CDK4/6 Inhibitor Plus Aromatase Inhibitor versus Fulvestrant in Chinese Patients with Hormone Receptor-Positive and Human Epidermal Growth Factor Receptor 2-Negative (HR+/HER2-) Advanced Breast Cancer |
| title_fullStr | Efficacy of CDK4/6 Inhibitor Plus Aromatase Inhibitor versus Fulvestrant in Chinese Patients with Hormone Receptor-Positive and Human Epidermal Growth Factor Receptor 2-Negative (HR+/HER2-) Advanced Breast Cancer |
| title_full_unstemmed | Efficacy of CDK4/6 Inhibitor Plus Aromatase Inhibitor versus Fulvestrant in Chinese Patients with Hormone Receptor-Positive and Human Epidermal Growth Factor Receptor 2-Negative (HR+/HER2-) Advanced Breast Cancer |
| title_pt_txt | Eficácia do Inibidor de CDK4/6 mais Inibidor de Aromatase versus Fulvestranto em Pacientes Chinesas com Câncer de Mama Avançado Receptor Hormonal-Positivo e Receptor do Fator de Crescimento Epidérmico Humano 2-Negativo (RH+/HER2-) |
| title_short | Efficacy of CDK4/6 Inhibitor Plus Aromatase Inhibitor versus Fulvestrant in Chinese Patients with Hormone Receptor-Positive and Human Epidermal Growth Factor Receptor 2-Negative (HR+/HER2-) Advanced Breast Cancer |
| title_sort | efficacy of cdk4/6 inhibitor plus aromatase inhibitor versus fulvestrant in chinese patients with hormone receptor-positive and human epidermal growth factor receptor 2-negative (hr+/her2-) advanced breast cancer |
| topic | Oncology General Oncology |
| url | https://www.dovepress.com/efficacy-of-cdk46-inhibitor-plus-aromatase-inhibitor-versus-fulvestran-peer-reviewed-fulltext-article-BCTT |